All Business Team members are RHI Shareholders

DR. LEE GOLDEN(Drug Development)

Lee Golden, M.D., joins RHI with more than 19 years in the Pharmaceutical and Biotech industries. He is currently the Head of Global Clinical Development at PTC Therapeutics, Inc and Chairman of the Board at Coagulation Science LLC. Dr. Golden first began his career at Pfizer Pharmaceuticals as a Medical Director. He then served in various senior leadership positions at Novartis Pharmaceuticals Corp., Elan Pharmaceuticals Inc., and Actelion Pharmaceuticals US, Inc.

ANDREW KOOPMAN(Investor Relations)

Andrew Koopman joins RHI with more than 30 years in the Biotechnology and Biomedical industries. He is currently a business development consultant and strategic advisor, working with universities, investors, biotechnology/biomedical startups, and incubators. He is also a member of the Board of Directors for PainQx, Inc., an officer in Applied Glycan Technologies, Inc., and an NIH SBIR mentor.